These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 9260604

  • 1. Effects of OK-432 (picibanil) on the estrogen receptors of MCF-7 cells and potentiation of antiproliferative effects of tamoxifen in combination with OK-432.
    Aoyagi H, Iino Y, Takeo T, Horii Y, Morishita Y, Horiuchi R.
    Oncology; 1997; 54(5):414-23. PubMed ID: 9260604
    [Abstract] [Full Text] [Related]

  • 2. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
    Kurebayashi J, Horiuchi R, Nakamura T, Iino Y, Ishida T, Takigawa H, Izuo M.
    Nihon Naibunpi Gakkai Zasshi; 1987 Nov 20; 63(11):1351-63. PubMed ID: 2965035
    [Abstract] [Full Text] [Related]

  • 3. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
    Chang HL, Sugimoto Y, Liu S, Ye W, Wang LS, Huang YW, Lin YC.
    Anticancer Res; 2006 Nov 20; 26(3A):1773-84. PubMed ID: 16827106
    [Abstract] [Full Text] [Related]

  • 4. Effects of OK-432 (Picibanil) on estrogen receptor levels and tamoxifen treatment in 7,12-dimethylbenz[a]anthracene-induced rat mammary cancers.
    Iino Y, Ogawa T, Yoshida M, Izuo M, Takikawa H.
    Oncology; 1990 Nov 20; 47(2):185-90. PubMed ID: 2107482
    [Abstract] [Full Text] [Related]

  • 5. Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro.
    Paulsen GH, Strickert T, Marthinsen AB, Lundgren S.
    Acta Oncol; 1996 Nov 20; 35(8):1011-9. PubMed ID: 9023387
    [Abstract] [Full Text] [Related]

  • 6. A naringenin-tamoxifen combination impairs cell proliferation and survival of MCF-7 breast cancer cells.
    Hatkevich T, Ramos J, Santos-Sanchez I, Patel YM.
    Exp Cell Res; 2014 Oct 01; 327(2):331-9. PubMed ID: 24881818
    [Abstract] [Full Text] [Related]

  • 7. Modulatory effect of tamoxifen and ICI 182,780 on adriamycin resistance in MCF-7 human breast-cancer cells.
    De Vincenzo R, Scambia G, Benedetti Panici P, Fattorossi A, Bonanno G, Ferlini C, Isola G, Pernisco S, Mancuso S.
    Int J Cancer; 1996 Nov 04; 68(3):340-8. PubMed ID: 8903476
    [Abstract] [Full Text] [Related]

  • 8. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J, Power KA, Mann J, Cheng A, Thompson LU.
    Exp Biol Med (Maywood); 2007 Sep 04; 232(8):1071-80. PubMed ID: 17720953
    [Abstract] [Full Text] [Related]

  • 9. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R, Tanabe K, Emi M, Uchida Y, Osaki A, Toge T.
    Int J Oncol; 2005 Apr 04; 26(4):1025-31. PubMed ID: 15753998
    [Abstract] [Full Text] [Related]

  • 10. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
    Chen J, Power KA, Mann J, Cheng A, Thompson LU.
    Nutr Cancer; 2007 Apr 04; 58(2):162-70. PubMed ID: 17640162
    [Abstract] [Full Text] [Related]

  • 11. Tumor growth inhibition, apoptosis, and Bcl-2 down-regulation of MCF-7ras tumors by sodium phenylacetate and tamoxifen combination.
    Adam L, Crépin M, Isräel L.
    Cancer Res; 1997 Mar 15; 57(6):1023-9. PubMed ID: 9067263
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effects of OK-432 (Picibanil) on cellular proliferation and adhesive capacity of breast carcinoma cells.
    Horii Y, Iino Y, Maemura M, Horiguchi J, Morishita Y.
    Oncol Rep; 2005 Feb 15; 13(2):289-94. PubMed ID: 15643513
    [Abstract] [Full Text] [Related]

  • 13. Additive growth inhibitory effects of ibandronate and antiestrogens in estrogen receptor-positive breast cancer cell lines.
    Journe F, Chaboteaux C, Magne N, Duvillier H, Laurent G, Body JJ.
    Breast Cancer Res; 2006 Feb 15; 8(1):R2. PubMed ID: 16417650
    [Abstract] [Full Text] [Related]

  • 14. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N, Keshamouni VG, Krueger JS, Schwartz JA, Miller F, Reddy KB.
    Oncogene; 2002 Jun 06; 21(25):4000-8. PubMed ID: 12037682
    [Abstract] [Full Text] [Related]

  • 15. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
    Revillion F, Pawlowski V, Lhotellier V, Louchez MM, Peyrat JP.
    Anticancer Res; 2003 Jun 06; 23(2B):1455-60. PubMed ID: 12820409
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antitumor and anticancer stem cell activities of eribulin mesylate and antiestrogens in breast cancer cells.
    Kurebayashi J, Kanomata N, Yamashita T, Shimo T, Moriya T.
    Breast Cancer; 2016 May 06; 23(3):425-36. PubMed ID: 25552385
    [Abstract] [Full Text] [Related]

  • 18. Relationship between tamoxifen-induced transforming growth factor beta 1 expression, cytostasis and apoptosis in human breast cancer cells.
    Perry RR, Kang Y, Greaves BR.
    Br J Cancer; 1995 Dec 06; 72(6):1441-6. PubMed ID: 8519657
    [Abstract] [Full Text] [Related]

  • 19. Combinatorial anti-proliferative effects of tamoxifen and naringenin: The role of four estrogen receptor subtypes.
    Xu Z, Huang B, Liu J, Wu X, Luo N, Wang X, Zheng X, Pan X.
    Toxicology; 2018 Dec 01; 410():231-246. PubMed ID: 30153467
    [Abstract] [Full Text] [Related]

  • 20. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
    Marsaud V, Gougelet A, Maillard S, Renoir JM.
    Mol Endocrinol; 2003 Oct 01; 17(10):2013-27. PubMed ID: 12855746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.